Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of clinical psychopharmacology - 42(2022), 5 vom: 01. Sept., Seite 502-503 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hansbauer, Maximilian [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 15.09.2022 Date Revised 23.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/JCP.0000000000001577 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344361845 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344361845 | ||
| 003 | DE-627 | ||
| 005 | 20231226022607.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/JCP.0000000000001577 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1147.xml |
| 035 | |a (DE-627)NLM344361845 | ||
| 035 | |a (NLM)35916561 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hansbauer, Maximilian |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.09.2022 | ||
| 500 | |a Date Revised 23.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 650 | 7 | |a Clozapine |2 NLM | |
| 650 | 7 | |a J60AR2IKIC |2 NLM | |
| 700 | 1 | |a Fastantz, Enikö |e verfasserin |4 aut | |
| 700 | 1 | |a Lutz, Justina |e verfasserin |4 aut | |
| 700 | 1 | |a Hasan, Alkomiet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical psychopharmacology |d 1993 |g 42(2022), 5 vom: 01. Sept., Seite 502-503 |w (DE-627)NLM012629219 |x 1533-712X |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:5 |g day:01 |g month:09 |g pages:502-503 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/JCP.0000000000001577 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2022 |e 5 |b 01 |c 09 |h 502-503 | ||